Polish Clinical Trials Market Reaches New Heights

  • Home
  • Newsroom
  • Polish Clinical Trials Market Reaches New Heights
Polish Clinical Trials Market Reaches New Heights - Axcellant

Polish Clinical Trials Market Reaches New Heights

  1. sie 20, 2024

Over the past two decades, the Polish CRO industry has transformed dramatically. What began with simple monitoring tasks has evolved into comprehensive offerings, covering full-process management, data analysis, and early-phase trials.

Today, the value of clinical trials in Poland stands at approximately €1.5 billion, contributing to an overall European market of around €12 billion, which is growing steadily at a rate of 5–6% year-on-year.

Thanks to private investments and robust scientific infrastructure, Poland and the CEE region have established a compelling position in global clinical research. Their emergence is a story of rapid evolution—from a supportive environment into a true innovation hub.

Marcel Zatoński (Puls Biznesu) helped highlight this transformation in a recent article. Don’t miss the full story: read the piece here (in Polish).

Read more

Axcellant partners with Prometheus MedTech.AI to accelerate AI-powered cardiac diagnostics

We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…

Axcellant at EANM 2025: What We Brought Back from Barcelona

The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…

Radioisotopes in Medicine: Clinical Applications, Safety, and Regulatory Considerations

The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…